Human breast cancer cell lines contain CD44+CD24–/lowESA+ cells that exhibit characteristic stem cell features like anchorage-independent growth at clonal densities, the ability to reconstruct the parental cell fractions, along with enhanced tumorigenicity in mice [9,31]. Here, CD24 is linked to breast carcinoma.